Ask AI
ProCE Banner Activity

A Deep Dive Into Complex Clinical Scenarios Involving Refractory CMV Infections

Slideset

Download these expert-curated slides to learn to design antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy.

Released: August 12, 2025

Share

Provided by

Provided by Clinical Care Options (CCO) in partnership with ProCE

ProCE Banner

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

ProCE, LLC

ProCE Banner

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Employ best practices for timely identification of refractory CMV infections following solid organ transplantation

  • Appropriately modify antiviral therapy in solid organ transplant recipients with treatment refractory CMV infections

  • Design antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy